Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 25 Late-Breaking Discussion: The BHF PROTECT-TAVI Trial
Author(s): Harriette Van Spall , Rajesh Kharbanda Added: 10 months ago
ACC 25 - PROTECT-TAVI shows no benefit to routine use of cerebral embolic protection during transcatheter aortic valve implantation (TAVI).Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Rajesh Kharbanda (Oxford University Hospitals NHS Foundation Trust, UK) to discuss the findings from the British Heart Foundation's PROTECT-TAVI Trial, which aimed to determine whether using… View more

Intervention

Vascular Disease and Surgery
EuroPCR 25: Meta-Analysis from PROTECTED TAVR and BHF PROTECT-TAVI
Author(s): Rajesh Kharbanda Added: 9 months ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without… View more

Intervention
Sudden Cardiac Death Risk in Newly Diagnosed Heart Failure: SCD-PROTECT
Author(s): Marat Fudim , David Duncker Added: 3 weeks ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19… View more

Electrophysiology & Arrhythmia

Heart Failure
ESC HFA 25: SCD-PROTECT
Author(s): Johann Bauersachs Added: 9 months ago
ESC HF 25 - SCD-PROTECT shows high risk of sudden cardiac arrest (SCA) and sudden cardiac death (SCD) during early medical therapy optimization for reduced LVEF in patients with new non-ischemic cardiomyopathy or MI/CAD.Prof Johann Bauersachs (Hannover Medical School, Hannover, DE) discusses findings from the SCD–PROTECT study, an investigation of sudden cardiac arrest in patients with newly… View more

MI/ACS

Heart Failure
Author(s): Felix Mahfoud, Ingo Ahrens, Thomas Cuisset ,et al Start date: Dec 03, 2024
Join us for an insightful webinar designed to enhance an understanding of the latest developments in pulmonary embolism (PE) management.Moderated by Prof Felix Mahfoud (University Hospital Basel, CH), the faculty will explore current guidelines with a critical eye, particularly where gaps may exist, such as in managing intermediate-risk patients. Featuring findings from the PEERLESS study, this… View more

Vascular Disease and Surgery
ESC HF 25: SCD-PROTECT
Author(s): Johann Bauersachs Added: 9 months ago
ESC HF 25 - SCD-PROTECT zeigt hohes Risiko für plötzlichen Herzstillstand (SCA) und plötzlichen Herztod (SCD) während der frühen medikamentösen Therapieoptimierung bei reduzierter LVEF bei Patienten mit neu diagnostizierter nicht-ischämischer Kardiomyopathie oder MI/KHK.Prof Johann Bauersachs (Medizinische Hochschule Hannover, Hannover, DE) diskutiert Ergebnisse aus dem SCD-PROTECT studie, einer… View more

MI/ACS

Heart Failure
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more

Heart Failure

Prevention & Chronic Conditions
TCT 24: The PEERLESS Trial
Author(s): Dr Wissam A Jaber Added: 1 year ago
TCT Conference 24 - PEERLESS II shows benefit of large-bore mechanical thrombectomy compared to catheter-directed thrombolysis for intermediate-risk pulmonary embolism (PE) patients.Dr Wissam A Jaber (Emory University Hospital Midtown, US) joins us onsite at TCT Conference to discuss the findings from PEERLESS (NCT06055920; Inari Medical).PEERLESS is a prospective, multicenter, randomized… View more

Anticoagulation

Intervention
ACC.24: The Embo-Abl Study
Author(s): Kengo Kusano Added: 1 year ago
ACC.24 — We are joined by Dr Kengo Kusano (National Cerebral and Cardiovascular Center, JP) to discuss the findings from the Embo-Abl Study.Embo-Abl is a multicenter prospective randomized study which aims to compare the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation (AF) between cryoballoon and radiofrequency ablation. 230 patients with AF from… View more

Electrophysiology & Arrhythmia
What’s Hot at ACC.26: Preview with Dr Latib & Prof Van Mieghem
Author(s): Nicolas M Van Mieghem , Azeem Latib Added: 6 days ago
What’s Hot at ACC.26: in this focused preview, Dr Azeem Latib (Montefiore Medical Center, US) and Prof Nicolas Van Mieghem, MD, PhD, pick out the late‑breaking clinical trials at ACC.26 that are most likely to influence practice for operators heading to New Orleans. In a fast, conversational format, they move from pulmonary embolism and left atrial appendage closure to heart failure, STEMI… View more

Imaging & Diagnostics

Intervention